A Prospective Study Identifying Predictive Factors of Cardia... : Hepatology A Prospective
Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular …

Fontan‐associated liver disease : Hepatology Fontan‐associated liver disease : Hepatology
AASLD Publications Hepatology Liver Transplantation Clinical Liver Disease Hepatology …

Background & Aims Non-alcoholic steatohepatitis (NASH) is a leading cause of chronic liver
disease in Western countries. Diagnosis of NASH requires a liver biopsy. We estimated the …

Abstract Background and Aims The evaluation of the natural history of NASH has been
limited. Currently, liver biopsy remains the gold standard in the assessment of NASH …

Background: Management guidelines from the American Association for the Study of Liver
Diseases/American College of Gastroenterology/American Gastroenterology Association …

Nonalcoholic fatty liver disease (NAFLD) is a global public health concern. Its natural history,
the development of nonalcoholic steatohepatitis (NASH) and fibrosis, is highly variable …

The long‐term survival of subjects with nonalcoholic fatty liver disease (NAFLD) in
comparison with both individuals with elevated transaminases attributable to other causes …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western
world, strongly associated with insulin resistance and the metabolic syndrome. Nonalcoholic …

Of all the aspects of non-alcoholic fatty liver disease (NAFLD), the slowest advances have
occurred in the therapeutic field. Thirty-five years after its formal description and after 15 …

Background and Aims Transjugular intrahepatic portosystemic shunt (TIPS) is now a
standard for the treatment of portal hypertension–related complications. After the TIPS …